Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer.
Whiteland H, Spencer-Harty S, Thomas DH, Davies C, Morgan C, Kynaston H, Bose P, Fenn N, Lewis PD, Bodger O, Jenkins S, Doak SH.
Whiteland H, et al. Among authors: davies c.
Exp Mol Pathol. 2013 Oct;95(2):220-6. doi: 10.1016/j.yexmp.2013.07.010. Epub 2013 Aug 6.
Exp Mol Pathol. 2013.
PMID: 23933194